Nodexon (Dexamethasone)

Dexamethasone, the active ingredient in Nodexon, is a corticosteroid presented as an oral tablet for oral use. It is employed to treat inflammatory disorders, allergic reactions, autoimmune diseases, certain cancers as part of chemotherapy regimens, and adrenal insufficiency replacement therapy. The product complies with European Union pharmaceutical standards and is marketed for hospital and clinical settings.

GNH USA supplies Nodexon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Dexamethasone is a glucocorticoid that modulates inflammatory and immune pathways across several disease categories. - Inflammatory disorders: reduces inflammation and associated pain or swelling. - Allergic reactions: suppresses hypersensitivity responses and edema. - Autoimmune diseases: dampens aberrant immune activity to limit tissue damage. - Certain cancers (as part of chemotherapy): mitigates chemotherapy‑induced inflammation and edema. - Adrenal insufficiency replacement therapy: provides glucocorticoid activity when endogenous production is inadequate.

Adverse reactions may occur with dexamethasone therapy and should be monitored.

Common Side Effects: - Increased appetite: may lead to weight gain. - Mood changes: irritability or euphoria. - Insomnia: difficulty falling or staying asleep. - Gastrointestinal discomfort: nausea or dyspepsia. - Elevated blood glucose: hyperglycemia, especially in diabetic patients.

Serious or Rare Side Effects: - Severe infection: due to immunosuppression. - Osteoporosis: bone demineralization with long‑term use. - Adrenal suppression: risk of withdrawal syndrome. - Peptic ulcer disease: gastrointestinal bleeding. - Psychiatric disturbances: psychosis or severe depression. - Vision changes: cataracts or glaucoma.

Before initiating therapy, consider patient‑specific factors and monitor for potential complications. - Pregnancy: safety not established; weigh benefits against risks. - Breastfeeding: excreted in milk; assess infant risk. - Diabetes: monitor blood glucose closely. - Hypertension: watch for blood pressure elevation. - Infections: avoid initiating therapy in uncontrolled systemic infections. - Store at ambient temperature below 25°C: keep in original packaging, protect from moisture and direct sunlight.

Dexamethasone can alter the pharmacokinetics or pharmacodynamics of several medicines.

Major Interactions (Avoid): - CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin): may increase dexamethasone exposure. - Anticoagulants (e.g., warfarin): enhanced anticoagulant effect, risk of bleeding.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): additive risk of gastrointestinal ulceration. - Vaccines (live attenuated): reduced vaccine efficacy. - Diuretics: may exacerbate hypokalemia. - Antidiabetic agents: may require dose adjustment due to hyperglycemia. - Antihypertensives: possible reduction in blood pressure control.